The Africa Health Security Index
The Index documents continent-wide gains across laboratory systems, biosurveillance, biosecurity and biosafety, manufacturing, and emergency response.
Analysis
Trending
AIxBio Horizon Scan: Spring 2026
Since the AIxBio Horizon Scan Winter 2025-2026 published in March 2026, there has been steady, incremental progress across AI-enabled biological tools. Protein design tools have continued to improve, agentic coding tools have matured in ways that lower barriers to computational biology, and commercial AI companies are making significant investments in the life sciences.
AIxBio Horizon Scan Winter 2025-2026
The AIxBio field stands at a critical juncture where rapid capability advances are outpacing governance frameworks and safety measures. The next 18 months will likely prove pivotal in determining whether voluntary safety practices by AI companies, emerging evaluation frameworks, and international coordination efforts can keep pace with technological development.
CACDA-NTI Joint Statement on Shared Priorities for Strengthened Biosecurity and Responsible AI-Biotechnology Innovation
China Arms Control and Disarmament Association (CACDA) and Nuclear Threat Initiative (NTI) Joint Statement on Shared Priorities for Strengthened Biosecurity & Responsible AI-Biotechnology Innovation
Developing Guardrails for AI Biodesign Tools
The integration of artificial intelligence (AI) with the life sciences offers tremendous potential benefits to society, but advances in AI biodesign tools also pose significant risks of misuse, with the potential for global consequences.
The Convergence of Artificial Intelligence and the Life Sciences
New report from NTI | bio offers recommendations for urgent actions that leaders within government, industry, the scientific community, and civil society should take to safeguard AI-bio capabilities.
Benchtop DNA Synthesis Devices: Capabilities, Biosecurity Implications, and Governance
A new NTI | bio report describes the status of benchtop DNA synthesis devices, explains the risks for biosecurity, and recommends action and oversight by governments, industry, and the scientific community.
The Biorisk Management Casebook: Insights into Contemporary Practices
Practical solutions for organizations involved in life science research to manage risks and prevent accidents, misuse, and other adverse outcomes stemming from their work.
Jaime Yassif on “The Need for Better Safeguarding of Bioscience”
In a new opinion piece for The Economist, Jaime Yassif makes the case for urgent action to create stronger guardrails for bioscience and biotechnology.
The Global Health Security Index
The first comprehensive assessment of global health security capabilities in 195 countries.